First Trust Advisors LP lessened its holdings in LifePoint Health Inc (NASDAQ:LPNT) by 12.1% in the second quarter, HoldingsChannel.com reports. The firm owned 434,659 shares of the company’s stock after selling 59,871 shares during the period. First Trust Advisors LP’s holdings in LifePoint Health were worth $21,211,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors have also added to or reduced their stakes in LPNT. Point72 Asia Hong Kong Ltd boosted its holdings in LifePoint Health by 1,897.5% in the first quarter. Point72 Asia Hong Kong Ltd now owns 2,417 shares of the company’s stock worth $114,000 after purchasing an additional 2,296 shares during the period. Bank of Montreal Can acquired a new position in LifePoint Health in the second quarter worth $169,000. Campbell & CO Investment Adviser LLC acquired a new position in LifePoint Health in the second quarter worth $211,000. Verition Fund Management LLC acquired a new position in LifePoint Health in the first quarter worth $224,000. Finally, Alambic Investment Management L.P. acquired a new position in LifePoint Health in the first quarter worth $240,000.
Several equities analysts have recently issued reports on the stock. Royal Bank of Canada downgraded shares of LifePoint Health from an “outperform” rating to a “sector perform” rating and set a $65.00 price target for the company. in a report on Tuesday, July 24th. William Blair downgraded shares of LifePoint Health from an “outperform” rating to a “market perform” rating in a report on Monday, July 23rd. Mizuho set a $65.00 price target on shares of LifePoint Health and gave the company a “hold” rating in a report on Monday, July 23rd. Credit Suisse Group boosted their price target on shares of LifePoint Health from $58.00 to $65.00 and gave the company a “neutral” rating in a report on Tuesday, July 24th. Finally, Zacks Investment Research downgraded shares of LifePoint Health from a “buy” rating to a “hold” rating in a report on Monday, July 16th. Three analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and two have given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus target price of $58.73.
LifePoint Health (NASDAQ:LPNT) last posted its quarterly earnings data on Friday, July 27th. The company reported $1.27 earnings per share for the quarter, topping the consensus estimate of $1.08 by $0.19. The business had revenue of $1.57 billion during the quarter, compared to the consensus estimate of $1.58 billion. LifePoint Health had a net margin of 0.65% and a return on equity of 7.04%. The company’s quarterly revenue was down 1.6% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.96 earnings per share. analysts anticipate that LifePoint Health Inc will post 4.59 EPS for the current fiscal year.
About LifePoint Health
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in the United States. Its hospitals provide a range of medical and surgical services, such as general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, rehabilitation, and pediatric, as well as specialized services, including open-heart surgery, skilled nursing, psychiatric care, and neuro-surgery.
Recommended Story: Outstanding Shares
Want to see what other hedge funds are holding LPNT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LifePoint Health Inc (NASDAQ:LPNT).
Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.